LeMaitre Vascular Toekomstige groei
Future criteriumcontroles 1/6
LeMaitre Vascular zal naar verwachting groeien in winst en omzet met respectievelijk 12.2% en 8.6% per jaar. De winst per aandeel zal naar verwachting groeien met 10.5% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 13.8% zijn.
Belangrijke informatie
12.2%
Groei van de winst
10.5%
Groei van de winst per aandeel
| Medical Equipment winstgroei | 17.2% |
| Inkomstengroei | 8.6% |
| Toekomstig rendement op eigen vermogen | 13.8% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 01 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
LeMaitre Vascular: The Market Is Catching On To This Dividend Growth Story
Nov 03LeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Nov 02
Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Potentially Undervalued?
Oct 08Investors Met With Slowing Returns on Capital At LeMaitre Vascular (NASDAQ:LMAT)
Sep 17LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Price In Tune With Earnings
Sep 04If EPS Growth Is Important To You, LeMaitre Vascular (NASDAQ:LMAT) Presents An Opportunity
Aug 22LeMaitre Vascular: A Small Cap With Best-In-Industry Growth
Jul 23Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$85.0 Based On Its Intrinsic Value?
Jul 12Is There Now An Opportunity In LeMaitre Vascular, Inc. (NASDAQ:LMAT)?
Jun 18Return Trends At LeMaitre Vascular (NASDAQ:LMAT) Aren't Appealing
Jun 05LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Popularity With Investors Is Clear
May 02Is Now The Time To Put LeMaitre Vascular (NASDAQ:LMAT) On Your Watchlist?
Apr 04Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Feb 29What Does LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Share Price Indicate?
Jan 19Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Paint A Concerning Picture
Oct 27Is It Too Late To Consider Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT)?
Oct 11Does LeMaitre Vascular (NASDAQ:LMAT) Deserve A Spot On Your Watchlist?
Aug 30The Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Don't Inspire Confidence
Jul 06Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$62.3 Based On Its Intrinsic Value?
May 20Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?
Mar 12Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?
Oct 23Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Oct 05LeMaitre Vascular (NASDAQ:LMAT) Could Be Struggling To Allocate Capital
Sep 13LeMaitre Vascular: Reiterate Buy Thesis Following Strong Q2 Numbers
Sep 08LeMaitre Vascular goes ex dividend tomorrow
Aug 23Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 259 | 56 | 59 | 66 | 7 |
| 12/31/2025 | 240 | 50 | 52 | 57 | 10 |
| 12/31/2024 | 220 | 44 | 34 | 46 | 10 |
| 9/30/2024 | 213 | 41 | 33 | 40 | N/A |
| 6/30/2024 | 206 | 38 | 32 | 37 | N/A |
| 3/31/2024 | 200 | 34 | 33 | 40 | N/A |
| 12/31/2023 | 193 | 30 | 29 | 37 | N/A |
| 9/30/2023 | 186 | 27 | 23 | 30 | N/A |
| 6/30/2023 | 177 | 25 | 19 | 26 | N/A |
| 3/31/2023 | 169 | 21 | 18 | 23 | N/A |
| 12/31/2022 | 162 | 21 | 22 | 25 | N/A |
| 9/30/2022 | 160 | 21 | 24 | 26 | N/A |
| 6/30/2022 | 160 | 22 | 29 | 33 | N/A |
| 3/31/2022 | 158 | 27 | 29 | 34 | N/A |
| 12/31/2021 | 154 | 27 | 30 | 35 | N/A |
| 9/30/2021 | 152 | 28 | 39 | 44 | N/A |
| 6/30/2021 | 151 | 29 | 40 | 44 | N/A |
| 3/31/2021 | 135 | 24 | 37 | 40 | N/A |
| 12/31/2020 | 129 | 21 | 32 | 35 | N/A |
| 9/30/2020 | 122 | 19 | 23 | 26 | N/A |
| 6/30/2020 | 115 | 16 | 13 | 17 | N/A |
| 3/31/2020 | 119 | 18 | 12 | 16 | N/A |
| 12/31/2019 | 117 | 18 | 10 | 14 | N/A |
| 9/30/2019 | 115 | 19 | 12 | 15 | N/A |
| 6/30/2019 | 111 | 18 | 12 | 15 | N/A |
| 3/31/2019 | 108 | 23 | 12 | 16 | N/A |
| 12/31/2018 | 106 | 23 | 16 | 20 | N/A |
| 9/30/2018 | 103 | 21 | 16 | 20 | N/A |
| 6/30/2018 | 104 | 22 | N/A | 24 | N/A |
| 3/31/2018 | 103 | 18 | N/A | 24 | N/A |
| 12/31/2017 | 101 | 17 | N/A | 23 | N/A |
| 9/30/2017 | 98 | 15 | N/A | 20 | N/A |
| 6/30/2017 | 96 | 14 | N/A | 18 | N/A |
| 3/31/2017 | 93 | 12 | N/A | 18 | N/A |
| 12/31/2016 | 89 | 11 | N/A | 17 | N/A |
| 9/30/2016 | 86 | 11 | N/A | 17 | N/A |
| 6/30/2016 | 82 | 9 | N/A | 14 | N/A |
| 3/31/2016 | 79 | 9 | N/A | 13 | N/A |
| 12/31/2015 | 78 | 8 | N/A | 11 | N/A |
| 9/30/2015 | 76 | 7 | N/A | 10 | N/A |
| 6/30/2015 | 74 | 6 | N/A | 9 | N/A |
| 3/31/2015 | 73 | 5 | N/A | 7 | N/A |
| 12/31/2014 | 70 | 4 | N/A | 6 | N/A |
| 9/30/2014 | 70 | 3 | N/A | 4 | N/A |
| 6/30/2014 | 67 | 3 | N/A | 4 | N/A |
| 3/31/2014 | 65 | 2 | N/A | 4 | N/A |
| 12/31/2013 | 64 | 3 | N/A | 5 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei LMAT ( 12.2% per jaar) ligt boven de spaarquote ( 2.6% ).
Winst versus markt: De winst van LMAT ( 12.2% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 15.5% per jaar).
Hoge groeiwinsten: De winst van LMAT zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van LMAT ( 8.6% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 9% per jaar).
Hoge groei-inkomsten: De omzet van LMAT ( 8.6% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen LMAT zal naar verwachting over 3 jaar laag zijn ( 13.8 %).